Medically Reviewed By: Halo Concierge Health
It depends on which peptide you mean. “Peptide therapy” can refer to FDA-approved prescription peptide medications (like GLP-1–based weight loss treatments), compounded peptides, or products that should never be used in humans (for example, anything labeled “for research use only”). Because the category is so broad, the safest way to think about this question is: there are a few “almost always no” situations, and a larger group of “only with close medical supervision.”
Some people should avoid peptide therapy entirely–especially when a peptide is contraindicated for their medical history (for example, certain GLP-1 medications in people with specific thyroid cancer risk). Others may still be candidates, but only with careful screening, a conservative plan, and ongoing monitoring.
If you are pregnant, trying to conceive soon, or breastfeeding, you should not start peptide therapy without explicit, condition-specific guidance from a qualified clinician. For GLP-1–based weight loss medications in particular, prescribing information includes pregnancy warnings and advises stopping when pregnancy is recognized (and, in some cases, stopping well in advance of a planned pregnancy due to long half-life).
If you've had a serious allergic reaction to a specific peptide medication (or its ingredients), you should not use that medication again. This is a straightforward safety issue and is explicitly addressed in prescribing information for GLP-1 receptor agonists.
Peptide therapy is usually not appropriate for children, whose endocrine, metabolic, and musculoskeletal systems are still developing. Pediatric use should be limited to specific, FDA-approved indications managed under specialty endocrine care, not pursued as a wellness or performance intervention.
Competitive athletes subject to anti-doping testing — including those competing at the NCAA, Olympic, or professional level — should not begin peptide therapy without first reviewing the current World Anti-Doping Agency (WADA) prohibited list with their physician. Many peptides used in regenerative medicine, including BPC-157, TB-500, and growth hormone secretagogues, are banned in or out of competition and can result in sanctions regardless of therapeutic intent or clinical context.
If the “peptide therapy” being offered is not a legitimate medication source–for example, products sold online as “research peptides” or “not for human consumption”–that’s a hard stop. The FDA has specifically warned consumers about unapproved GLP-1 products being illegally sold under “research use” labels and urged people not to purchase them due to unknown quality and potential harm.
For GLP-1–based weight loss therapy (often what people mean by “peptides for weight loss”), there are clear contraindications. For example, Wegovy (semaglutide) is contraindicated in people with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
GLP-1 therapies are also generally not recommended in severe gastroparesis, because these medications delay gastric emptying and can worsen significant motility problems.
A large middle group isn’t “never”–it’s “only if we’re careful.”
If you have a history of pancreatitis, gallbladder disease, or you develop severe abdominal symptoms after starting therapy, GLP-1 medication labels include warnings to discontinue promptly if pancreatitis is suspected and note limited experience in people with prior pancreatitis. That doesn’t automatically mean you can’t ever use them, but it does mean risk/benefit and monitoring should be handled conservatively.
If you have kidney vulnerability or frequent dehydration, it’s important to discuss this before starting–especially because nausea/vomiting/poor intake can lead to volume depletion and worsen renal function risks in susceptible people.
If you have active depression, new mood changes, or a history of suicidal thoughts, that should be discussed up front. Some GLP-1 prescribing information includes monitoring language for depression/suicidal thoughts and discontinuation if symptoms develop.
If you have planned surgery or procedures requiring anesthesia/sedation, tell your prescribing clinician and your anesthesia team. GLP-1 therapies delay gastric emptying, and labels describe rare post marketing reports of aspiration during anesthesia/deep sedation with residual gastric contents despite fasting guidance–so timing adjustments may be needed.
For templated content, the cleanest message is: don’t self-source peptides and don’t treat “peptides” like one product category. A reputable clinic should be able to tell you exactly what peptide is being used, whether it’s FDA-approved or compounded, why it fits your goals, what risks apply to you, and how they’ll monitor outcomes and side effects over time.
Learn More About Peptides and Medical Weight Loss
If you’re considering peptide therapy, the safest next step is a structured consult to (1) clarify which peptide you mean, (2) screen for contraindications and red flags, and (3) choose a monitoring plan you can stick with.
Ready to talk it through? Book a discovery consult with us (telehealth available where permitted)
The evidence for “peptide therapy” safety and eligibility is best represented by (1) prescribing information that defines contraindications and warnings for commonly used peptide-based medications (especially GLP-1 therapies), (2) regulatory safety communications about unapproved products, and (3) peer-reviewed reviews/meta-analyses summarizing adverse event patterns.
Helping people live a more balanced & healthier life isn't just our job, it's our passion! We believe that having hormone balance is key for lifelong, optimal health + wellness, and we take our mission very seriously... incorporating the latest scientific advances and dedicated to the very best care possible.
Halo Concierge Health is located in Raleigh, NC and serves practice members throughout North Carolina and Virginia. These areas include but are not limited to Raleigh, Wake Forest, Durham, Chapel Hill, Cary, Morrisville, Apex, Holly Springs, Fuquay-Varina, Garner, Clayton, Rolesville, Zebulon, and Mebane with options for follow-up telemedicine appointments.